Incidence and risk factors for pneumonitis due to trastuzumab Deruxtecan in metastatic breast cancer: a retrospective cohort study. Azhar M, Soto F, Su A, Gonzalez NAV, et al. Breast Cancer Res 2025;27:197.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Azhar M, Soto F, Su A, Gonzalez NAV, et al. Incidence and risk factors for pneumonitis due to trastuzumab Deruxtecan in metastatic breast cancer: a retrospective cohort study. Breast Cancer Res 2025;27:197.
PMID: 41194091